SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615774-17-004283
Filing Date
2017-08-11
Accepted
2017-08-11 16:52:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 s107151_s3.htm S-3 496083
2 EXHIBIT 5.01 s107151_ex5-01.htm EX-5.01 34500
3 EXHIBIT 23.01 s107151_ex23-01.htm EX-23.01 2791
4 GRAPHIC logo_s3.jpg GRAPHIC 12250
5 GRAPHIC logo1_s3.jpg GRAPHIC 9044
  Complete submission text file 0001615774-17-004283.txt   564037
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-219930 | Film No.: 171025782
SIC: 2834 Pharmaceutical Preparations